Recent Updates — HITI
High Tide Inc. completed the acquisition of an established retail cannabis store located at 100 Rainbow Road in Chestermere, Alberta, for $670,000 in cash on October 8, 2026. The transaction represents a multiple of 2.1 times annualized Adjusted EBITDA based on approximately $316,000 for the three months ended August 31, 2026. The store will be rebranded under High Tide's Canna Cabana banner, bringing the company's total location count to 234 across Canada and 93 in Alberta. High Tide Inc. is a retail-forward cannabis enterprise operating the largest cannabis retail chain in Canada.
High Tide Inc. announced that its Canna Cabana brand leads Canadian cannabis retailers in brand awareness, with national awareness rising to 36% from 29% in Q3 2025 and 11% at launch. The company granted 103,000 incentive stock options to employees, exercisable at the prior day's TSXV closing price, expiring in three years with two-year vesting. High Tide operates as a retail-forward cannabis enterprise, owning Canna Cabana, Canada's largest cannabis retail chain, and Remexian Pharma GmbH, a German medical cannabis distributor.
High Tide Inc. reported record-breaking financial results for its third fiscal quarter ended July 31, 2026. Revenue reached $198.8 million, a 33% increase year-over-year, while net income surged to $12.7 million from $0.8 million in the prior year period. Adjusted EBITDA hit a record $16.2 million, and free cash flow totaled $7.0 million. The company also closed a $40 million senior secured credit facility with Bank of Montreal and announced the opening of three new Canna Cabana locations, bringing its total Canadian store count to 232. High Tide Inc. operates in the cannabis industry, focusing on retail through Canna Cabana and medical distribution via Remexian.
High Tide Inc. filed its unaudited interim financial statements and management discussion & analysis for the three and nine months ended July 31, 2026. Revenue increased 33% year-over-year to $198.8 million CAD in Q3, driven by a $38.2 million contribution from the medical cannabis distribution segment acquired via Remexian and organic growth in its bricks-and-mortar retail operations. Gross profit rose 32% to $52.7 million CAD with margins stable at 27%. Adjusted EBITDA grew 53% to $16.2 million CAD, yielding an 8% margin. Net income was $12.7 million CAD compared to a loss in the prior year period. The company operates as Canada's largest cannabis retail chain and distributes medical cannabis in Germany.